These findings corroborate to our study on the association of Lp(a) with new-onset T2D and NAFLD in the context of statin use, and to adjust for triglycerides when examining the association of Lp(a) with T2D and NAFLD. This evidence concerns the gene LPA and type 2 diabetes mellitus.